ArticleTranslational and clinical pharmacology2017

Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis.

Choon Ok Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.